XTRA:MRKPharmaceuticals
Merck KGaA XTRA MRK Margin Decline Challenges Bullish Profitability Narratives
Merck KGaA (XTRA:MRK) closed out FY 2025 with fourth quarter revenue of €5.2b and basic EPS of €0.74, while full year trailing twelve month revenue came in at €21.1b with EPS of €6.00, giving investors a clear view of both the latest quarter and the broader run rate. Over recent periods, revenue has moved in a tight band between €5.2b and €5.4b per quarter and quarterly EPS has ranged from €0.74 to €2.07, which helps frame how the current quarter sits against the last few earnings updates...